Article Details
Retrieved on: 2018-02-11 19:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Benchmark Capital</b> Advisors increased its stake in Aerie Pharmaceuticals Com (AERI) by 119.4% based on its latest 2017Q3 regulatory filing with the SEC. <b>Benchmark Capital</b> Advisors bought 16,000 shares as the company's stock declined 8.47% while stock markets rallied. The institutional investor ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here